Browse > Article
http://dx.doi.org/10.15230/SCSK.2016.42.4.337

Use of Redness Assessment in Melasma Lesions in Skin Whitening Evaluation  

Lee, Jung Ah (Ellead co., Ltd.)
Kim, Ju Yeon (Ellead co., Ltd.)
Lee, Sun Hwa (Ellead co., Ltd.)
Kim, Bora (Ellead co., Ltd.)
Kim, Nam Soo (Ellead co., Ltd.)
Moon, Tae Kee (Ellead co., Ltd.)
Publication Information
Journal of the Society of Cosmetic Scientists of Korea / v.42, no.4, 2016 , pp. 337-342 More about this Journal
Abstract
Melasma has several well-recognized etiologic factors, but most researches focus on melanogenesis. The purpose of this study is to show improvement of melasma by reducing vascularity distinguished from melanogenesis. We examined 20 Korean women with both melasma and solar lentigo that were visually assessed by a dermatologist. The volunteers applied functional cosmetics for 8 weeks. We analyzed the results obtained using the chromameter, evaluating the skin color of three areas (melasma lesions, solar lentigo lesions, and non-lesional skin) on the face of volunteer. There was a statistically significant improvement in the brightness and redness of melasma lesions compared to those of non-lesional skin after 8 weeks. Also, we observed that the improvements in the brightness of melasma lesions and solar lentigo lesions were similar. However, the redness of melasma lesions improved more than that of solar lentigo lesions with statistical significance after 8 weeks. In this study, we have shown that brightness and redness in melasma lesions can be improved by functional cosmetics. Thus, we suggest redness to be an additional suitable parameter for the evaluation of melasma lesions.
Keywords
melasma lesions; lentigo lesions; non-lesional skin; redness; vascularity;
Citations & Related Records
연도 인용수 순위
  • Reference
1 A. C. Handel, L. D. Miot, and H. A. Miot, Melasma: a clinical and epidemiological review, An. Bras. Dermatol., 89(5), 771 (2014).   DOI
2 D. L. Bissett, K. Miyamoto, P. Sun, J. Li, and C. A. Berge, Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin, Int. J. Cosmet. Sci., 26(5), 231 (2004).   DOI
3 S. Im, J. Kim, W. Y. On, and W. H. Kang, Increased expression of alpha-melanocyte-stimulating hormone in the lesional skin of melasma, Br. J. Dermatol., 146(1), 165 (2002).   DOI
4 D. J. Lee, J. Lee, J. Ha, K. C. Park, J. P. Ortonne, and H. Y. Kang, Defective barrier function in melasma skin, J. Eur. Acad. Dermatol. Venereol., 26(12), 1533 (2012).   DOI
5 E. H. Kim, Y. C. Kim, E. S. Lee, and H. Y. Kang, The vascular characteristics of melasma, J. Dermatol. Sci., 46(2), 111 (2007).   DOI
6 W. H. Kang, K. H. Yoon, E. S. Lee, J. Kim, K. B. Lee, H. Yim, S. Sohn, and S. Im, Melasma: histopathological characteristics in 56 Korean patients, Br. J. Dermatol., 146(2), 228 (2002).   DOI
7 Y. H. Jang, J. H. Sim, H. Y. Kang, Y. C. Kim, and E. S. Lee, The histopathological characteristics of male melasma: comparison with female melasma and lentigo, J. Am. Acad. Dermatol., 66(4), 642 (2012).   DOI
8 R. Sarkar, P. Arora, and K. Garg, Cosmeceuticals for hyperpigmentation: what is available?, J. Cutan. Aesthet. Surg., 6(1), 4 (2013).   DOI
9 J. Navarrete-Solis, J. P. Castanedo-Cazares, B. Torres-Alvarez, C. Oros-Ovalle, C. Fuentes-Ahumada, F. J. Gonzalez, J. D. Martinez-Ramirez, and B. Moncada, A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma, Dermatol. Res. Pract., 2011, 379173 (2011).
10 T. Hakozaki, L. Minwalla, J. Zhuang, M. Chhoa, A. Matsubara, K. Miyamoto, A. Greatens, G. G. Hillebrand, D. L. Bissett, and R. E. Boissy, The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer, Br. J. Dermatol., 147(1), 20 (2002).   DOI
11 N. Akhtar, M. S. Khan, A. Iqbal, B. A. Khan, and S. Bashir, Glycyrrhiza glabra extract cream: effects on skin pigment melanin, International Conference on Bioscience, Biochemistry and Bioinformatics, 5, 434 (2011).
12 F. C. Victor, J. Gelber, and B. Rao, Melasma: a review, J. Cutan. Med. Surg., 8(2), 97 (2004).   DOI
13 T. Yokota, H. Nishio, Y. Kubota, and M. Mizoguchi, The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation, Pigment. Cell Res., 11(6), 355 (1998).   DOI
14 L. Zaleski, S. Fabi, and M. P. Goldman, Treatment of melasma and the use of intense pulsed light: a review, J. Drugs Dermatol., 11(11), 1316 (2012).
15 S. Rahrovan, H. Hasanzadeh, S. Khodakarim, and A. Firooz, Biophysical characteristics of melasma skin comparing with the perilesional normal skin and its relation to the melasma subtype, J. Pigment. Disord., 2(11), 222 (2015).
16 D. Kovacs, G. Cardinali, N. Aspite, C. Cota, F. Luzi, B. Bellei, S. Briganti, A. Amantea, M. R. Torrisi, and M. Picardo, Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo, Br. J. Dermatol., 163(5), 1020 (2010).   DOI
17 R. G. Langley, E. Burton, N. Walsh, I. Propperova, and S. J. Murray, In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna, J. Am. Acad. Dermatol., 55(1), 88 (2006).   DOI
18 Y. Kaymak and M. Onder, An investigation of efficacy of topical niacinamide for the treatment of mild and moderate acne vulgaris, J. Turk. Acad. Dermatol., 2(4), jtad82402a (2008).
19 J. Wohlrab and D. Kreft, Niacinamide - mechanisms of action and its topical use in dermatology, Skin Pharmacol. Physiol., 27(6), 311 (2014).   DOI
20 Z. D. Draelos, K. Ertel, and C. Berge, Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea, Cutis, 76(2), 135 (2005).